About Inmedix
Inmedix is a Healthcare company based in Burien (United States) founded in 2006. Auto-immune diseases are diagnosed through a specialized device. Inmedix has raised $745 thousand across 4 funding rounds. Inmedix offers products and services including CloudHRV System. Its focus areas include Life Sciences, Immunology and Medical Devices. Its legal entity is INMEDIX UK LTD. Its competitors include SetPoint Medical, Boomerang Medical and Therakos; 2 of its 3 listed competitors have raised funding.
Company details
Founded in 2006 and based in Burien, United States, the company operates in the medical diagnostics sector. A device known as ANS Neuroscan is developed to assess heart rate variability, enabling detection of autonomic nervous system stress. Such stress is associated with auto-immune conditions including rheumatoid arthritis, fibromyalgia, and multiple sclerosis. Operations focus on providing diagnostic tools for healthcare applications.
- Headquarters Burien, United States
- SectorsHealthcare
- Phone•••• ••••
- Website inmedix.com
- Social LinkedIn
- Legal Name Inmedix Uk Ltd
- Total Equity Funding$745K (USD)
in 4 rounds
- Latest Funding Round$159.98K (USD), Debt – Conventional
Sep 2025
Products & Services of Inmedix
Inmedix offers a comprehensive portfolio of products and services, including CloudHRV System.
FDA-cleared system for monitoring heart rate variability in medical diagnostics.
Funding Insights of Inmedix
Inmedix has successfully raised a total of $745K across 4 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $159.98 thousand completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $745,000
- Total Rounds 4
- Last Round Debt – Conventional — $159,980
- First Round $470,000
(Mar 2021)
All 4 funding rounds of Inmedix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2025 | $159,980 | Debt – Conventional | – | – | – |
| Aug 2024 | $720,000 | Seed | – | – | – |
| Apr 2023 | $25,000 | Seed | – | – | – |
| Mar 2021 | $470,000 | Debt – Conventional | – | – | – |
People of Inmedix
25 people are tracked at Inmedix (5 in leadership, 19 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Andrew J. Holman | Co-Founder, Director & CEO | Leadership |
Glynis Thakur | Director, Finance & Reimbursement | Leadership |
Steven Daly | COO & Director | Leadership |
Nathan A. Smith | Chief Financial Officer | Leadership |
Jolene Anderson | Senior Director, Wellness Initiative | Leadership |
Alex Bangs | Company Advisor | Board & advisors |
Leroy Hood | Director | Board & advisors |
T V Sciarrillo | Co-Founder | Board & advisors |
Vibeke Strand | Scientific Advisor | Board & advisors |
Peter Taylor | Scientific Advisor | Board & advisors |
Ernest Choy | Scientific Advisor | Board & advisors |
Michael E. Weinblatt | Scientific Advisor | Board & advisors |
Norman B. Gaylis | Scientific Advisor | Board & advisors |
Daniel E. Furst | Scientific Advisor | Board & advisors |
Bernie Tobin | Director | Board & advisors |
James O’Dell | Scientific Advisor | Board & advisors |
Robert E. Ettlinger | Scientific Advisor | Board & advisors |
Leonard Calabrese | Scientific Advisor | Board & advisors |
Leslie Bottorff | Company Advisor | Board & advisors |
Eli Loots | Company Advisor | Board & advisors |
5 more people are available in the full profile.
Complete people profiles for Inmedix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Inmedix
3 dated milestones of Inmedix across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Inmedix is founded.
- Funding First funding round of $470K.
- Funding Latest funding round, Debt – Conventional, of $160K.
Competitors of Inmedix
Inmedix has 3 listed competitors in our database, 2 of them funded. They include SetPoint Medical, Boomerang Medical and Therakos.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| setpointmedical.com | 2006 | Santa Clarita, United States | $363.17M | 46 | Implantable neuromodulation devices are developed for inflammatory diseases. | |
| boomerangmedical.com | 2021 | Mountain View, United States | $35M | Bioelectronic devices are developed for autoimmune disease treatment. | ||
| therakos.com | 1984 | West Chester, United States | Therakos is focused on photopheresis systems for CTCL treatment. |
Detailed competitors of Inmedix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Inmedix
The website of Inmedix (inmedix.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▲ 3.3% vs previous month
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as Inmedix (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Inmedix
Inmedix was founded in 2006 and raised its 1st funding round 15 years after it was founded.
Inmedix is headquartered in Burien, United States. It is registered at Burien, Washington, United States.
Inmedix is a funded company, having raised a total of $745K across 4 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $470K, raised on Mar 2021.
Founded in 2006 and based in Burien, United States, the company operates in the medical diagnostics sector. A device known as ANS Neuroscan is developed to assess heart rate variability, enabling detection of autonomic nervous system stress. Such stress is associated with auto-immune conditions including rheumatoid arthritis, fibromyalgia, and multiple sclerosis. Operations focus on providing diagnostic tools for healthcare applications.
Inmedix's top competitors include SetPoint Medical, Boomerang Medical and Therakos.
Inmedix offers CloudHRV System.
Inmedix operates through Inmedix Uk Ltd.